Solid Biosciences (SLDB) Total Non-Current Liabilities (2018 - 2024)
Solid Biosciences (SLDB) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $22.0 million as the latest value for Q3 2024.
- Quarterly Total Non-Current Liabilities changed N/A to $22.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $22.0 million through Sep 2024, changed N/A year-over-year, with the annual reading at $23.9 million for FY2023, 50.63% down from the prior year.
- Total Non-Current Liabilities hit $22.0 million in Q3 2024 for Solid Biosciences, down from $23.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $48.5 million in Q4 2022 to a low of $22.0 million in Q3 2024.
- Historically, Total Non-Current Liabilities has averaged $31.0 million across 4 years, with a median of $23.9 million in 2023.
- Biggest YoY gain for Total Non-Current Liabilities was 50.63% in 2023; the steepest drop was 50.63% in 2023.
- Year by year, Total Non-Current Liabilities stood at $37.8 million in 2020, then increased by 28.34% to $48.5 million in 2022, then crashed by 50.63% to $23.9 million in 2023, then fell by 8.32% to $22.0 million in 2024.
- Business Quant data shows Total Non-Current Liabilities for SLDB at $22.0 million in Q3 2024, $23.0 million in Q2 2024, and $23.9 million in Q4 2023.